Lung Cancer Update

Dr. Neil Love•66 avsnitt•1 tim•Varannan vecka

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Avsnitt

· 66

Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer

14 aug. 20241 tim 2 min

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

5 aug. 20241 tim 1 min

Oncology Today with Dr Neil Love: An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation

25 juli 202448 min

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer

12 juni 20241 tim 1 min

Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates

4 apr. 20241 tim 14 min

Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer

20 mars 20241 tim 3 min

Implications of Recent Data Sets for the Current and Future Management of Lung Cancer

11 dec. 20231 tim 30 min

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer

16 okt. 20231 tim 2 min

Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy

8 sep. 20232 tim 44 min

Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

22 aug. 202332 min

Lung Cancer Update med Dr. Neil Love finns tillgänglig på flera plattformar. Poddens innehåll och bilderna på den här webbplatsen hämtas med hjälp av poddens RSS-flöde.